Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 1, 2005, Pages 96-102

  Apostolov, Eugene ^a,b   Abu Al Soud, Waleed ^a   Nilsson, Ingrid ^a   Kornilovska, Iryna ^c   Usenko, Vasiliy ^c   Lyzogubov, Valerij ^c   Gaydar, Yuri ^b   Wadström, Torkel ^a   Ljungh, Åsa ^a  

^a LUND UNIVERSITY   (Sweden)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^c Morphological Laboratory BIONTEC   (Ukraine)

Author keywords

Gallbladder; Helicobacter; Immunostaining; Liver; PCR DGGE

Indexed keywords

BACTERIAL ANTIGEN; CAGA CYTOTOXIN; CYTOTOXIN; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; MOLECULAR MARKER; SOLUBLE SURFACE PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BILE; CAMPYLOBACTER JEJUNI; CHRONIC CHOLECYSTITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; FEMALE; GALLBLADDER; GALLBLADDER BIOPSY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HELICOBACTER; HELICOBACTER BILIS; HELICOBACTER HEPATICUS; HELICOBACTER PYLORI; HEPATOBILIARY SYSTEM; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TECHNIQUE; LIVER; LIVER BIOPSY; LIVER DISEASE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEQUENCE ANALYSIS; TISSUE SECTION; UKRAINE;

ADULT; AGED; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLECYSTITIS; CHRONIC DISEASE; COHORT STUDIES; DNA, BACTERIAL; FEMALE; GALLBLADDER; HELICOBACTER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 12444268265     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410009546     Document Type: Article

References (39)

1. IARC. Working Group on the evaluation of carcinogenic risks to human: Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC Monogr Eval Carcinog Risks Hum; 1994 June 7-14.
2. Dohmen K, Shigematsu H, Miyamoto Y, Yamasaki F, Irie K, Ishibashi H. Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis. Dig Dis Sci 2002;47:162-9.
3. Kinjo K, Sato H, Shiotani I, Kurotobi T, Ohnishi Y, Hishida E, et al. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circ J 2002;66:805-10.
4. Raderer M, Wrba F, Kornek G, Maca T, Koller DY, Weinlaender G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998;55:16-9.
5. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001;96:3406-10.
6. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998;114:755-63.
7. Monstein HJ, Jonsson Y, Zdolsek J, Svanvik J. Identification of Helicobacter pylori DNA in human cholesterol gallstones. Scand J Gastroenterol 2002;37:112-9.
8. Wadström T, Ljungh Å, Willen R. Primary biliary cirrhosis and primary sclerosing cholangitis are of infectious origin! Gut 2001;49:454.
9. Metz DC. Helicobacter colonization of the biliary tree: commensal, pathogen, or spurious finding? Am J Gastroenterol 1998;93:1996-8.
10. Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, et al. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation? Dig Dis Sci 1998;43:854-62.
11. Wadström T, Abu Al-Soud W, Ljungh Å, Nilsson H-O, Stenram U. Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer. Hepatology 2003;38:532-3; author reply 33.
12. Mendez-Sanchez N, Pichardo R, Gonzalez J, Sanchez H, Moreno M, Barquera F, et al. Lack of association between Helicobacter sp. colonization and gallstone disease. J Clin Gastroenterol 2001;32:138-41.
13. Harada K, Ozaki S, Kono N, Tsuneyama K, Katayanagi K, Hiramatsu K, et al. Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis. J Pathol 2001;193:218-23.
14. Fox J, Yan L, Dewhirst F, Paster B, Shames B, Murphy J, et al. Helicobacter bills sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 1995;33:445-54.
15. Sorlin P, Vandamme P, Nortier J, Hoste B, Rossi C, Pavlof S, et al. Recurrent "Flexispira rappini" bacteremia in an adult patient undergoing hemodialysis: case report. J Clin Microbiol 1999;37:1319-23.
16. Fox J. Enterohepatic Helicobacters: natural and experimental models. Ital J Gastroenterol Hepatol 1998;30:S264-9.
17. Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002;93:842-7.
18. Saltanova SD. Prevalence of Helicobacter pylori among children and juveniles as evidenced by the 13C urea breath test. Lik Sprava 2001;174-6.
19. Kornilovska I, Nilsson I, Utt M, Ljungh A, Wadström T. Immunogenic proteins of Helicobacter pullorum, Helicobacter bilis and Helicobacter hepaticus identified by two-dimensional gel electrophoresis and immunoblotting. Proteomics 2002;2:775-83.
20. Goto K, Ohashi H, Takakura A, Itoh T. Current status of helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan. Curr Microbiol 2000;41:161-6.
21. Abu Al-Soud W, Bennedsen M, On SLW, Ouis I-S, Vandamme P, Nilsson H-O, et al. Assessment of PCR-DGGE for the identification of diverse Helicobacter species, and application to faecal samples from zoo animals to determine helicobacter prevalence. J Med Microbiol 2003;52:765-71.
22. Nilsson I, Ljungh Å, Aleljung P, Wadström T. Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol 1997;35:427-32.
23. Kawaguchi M, Saito T, Ohno H, Midorikawa S, Sanji T, Handa Y, et al. Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol 1996;31:294-8.
24. Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002;95:1946-53.
25. Roe IH, Kim JT, Lee HS, Lee JH. Detection of Helicobacter DNA in bile from bile duct diseases. J Korean Med Sci 1999;14:182-6.
26. Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO, Kim HJ, et al. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci 2000;45:1405-12.
27. Andersen LP, Dorland A, Karacan H, Colding H, Nilsson H-O, Wadström T, et al. Possible clinical importance of the transformation of Helicobacter pylori into coccoid forms. Scand J Gastroenterol 2000;35:897-903.
28. Nilsson H-O, Blom J, Abu Al-Soud W, Ljungh A, Andersen LP, Wadström T. Effect of cold starvation, acid stress, and nutrients on metabolic activity of Helicobacter pylori. Appl Environ Microbiol 2002;68:11-9.
29. Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 2001;15:1271-90.
30. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med 2002;33:323-36.
31. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999;96:14559-64.
32. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500.
33. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 2001;42:1337-48.
34. Massari P, Manetti R, Burroni D, Nuti S, Norais N, Rappuoli R, et al. Binding of the Helicobacter pylori vacuolating cytotoxin to target cells. Infect Immun 1998;66:3981-4.
35. Willhite DC, Ye D, Blanke SR. Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells. Infect Immun 2002;70:3824 -32.
36. Ljungh Å, Wadström T. The role of microorganisms in biliary tract disease. Curr Gastroenterol Rep 2002;4:167-71.
37. Fox JG. The non-H. pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 2002;50:273-83.
38. Di Leo A, Messa C, Russo F, Linsalata M, Amati L, Caradonna L, et al. Helicobacter pylori infection and host cell responses. Immunopharmacol Immunotoxicol 1999;21:803-46.
39. Blanchard TG, Czinn SJ, Nedrud JG. Host response and vaccine development to Helicobacter pylori infection. Curr Top Microbiol Immunol 1999;241:181-213.